From a mechanistic perspective, sulfonylureas may facilitate tumor formation and progression via their insulin secretagogue properties [102]
More likely, the CV protection afforded by empagliflozin resulted from its beneficial hemodynamic effects including reduced blood pressure (after load reduction), decreased intravascular volume (preload reduction), and diminished aortic stiffness (after load reduction) (46)
Prendin F, Cappon G, Tripyla A, Herzig D, Bally L, Facchinetti A
higher-dose version submitted for FDA approval for weight loss
Key Benefits of BPC-157 Anti-inflammatory (without immune suppression) BPC-157 doesnt shut down your immune system like steroids or NSAIDs
It is produced in the small intestine and regulates blood sugar balance and appetite